Related Experiment Video
Updated: Aug 17, 2026

A Chronic Cardiac Ischemia Model in Swine Using an Ameroid Constrictor
Published on: October 9, 2017
Surreptitious superwarfarin ingestion with brodifacoum
R G Berry1, J A Morrison, J W Watts
1Columbus County Hospital, Whiteville, NC, USA.
Abstract:
Physicians must have a high index of suspicion when patients have unexplained prolongation of the prothrombin time and bleeding in the absence of detectable warfarin. Several common rodenticides contain modified versions of warfarin that are not detectable in standard warfarin assays. We present a case of surreptitious brodifacoum ingestion in a patient who had years of unexplained bleeding and negative warfarin levels.
Insights
Physicians should suspect uncommon causes of bleeding, like rodenticide ingestion, when standard tests are negative. Brodifacoum, a warfarin-like rodenticide, can cause prolonged bleeding without detectable warfarin levels.
Area of Science:
- Toxicology
- Hematology
Background:
- Unexplained bleeding and prolonged prothrombin time (PT) in patients warrant thorough investigation.
- Standard warfarin assays may not detect anticoagulant rodenticides.
Observation:
- A patient presented with a history of unexplained bleeding and elevated PT.
- Warfarin levels were consistently undetectable.
Findings:
- The patient's symptoms were attributed to surreptitious ingestion of brodifacoum, a potent anticoagulant rodenticide.
- Brodifacoum is a modified warfarin derivative not detected by standard warfarin assays.
Implications:
- Clinicians must consider non-standard anticoagulant exposures in cases of unexplained bleeding.
- Diagnostic assays for anticoagulant rodenticides should be considered in specific clinical scenarios.
Related Concept Videos
Prevention of Further Absorption of Poison
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical Poisoning: Treatment Strategies

